Sort by
Refine Your Search
-
equality and diversity as a strength and an asset. Subject description The research will focus on the development of novel radical-based transformations aimed at expanding chemical space and enabling
-
during the interview) v) A draft Individual Career Development Plan (ICDP) vi) Two reference letters vii) Any other supporting documents viii) Ethical questionnaire (HE ethics checklist + research ethics
-
wishes to bring onboard 4. Evidence of English proficiency (minimum CEFR B22, also checked at interview) 5. A draft Individual Career Development Plan (ICDP) 6. Two reference letters 7. Any additional
-
of nanoparticle-based materials. The aim of the research is to develop new types of materials based on nanoparticles with new properties, and to understand the link between the properties of the material and how
-
partners the candidate wishes to bring onboard 4. Evidence of English proficiency (minimum CEFR B22, also checked at interview) 5. A draft Individual Career Development Plan (ICDP) 6. Two reference letters 7
-
on the bioinformatics program. Qualification requirements Appointment to this career development position requires that the applicant has a PhD, or an international degree deemed equivalent to a PhD
-
). v) A draft Individual Career Development Plan (ICDP). vi) Two reference letters. vii) Any additional documents to support the application. viii) Ethical questionnaire (HE ethics checklist + research
-
will play a key role in the development of programmable CIS/BIS, combining structural biology, microbiome analysis, and protein engineering to create novel precision delivery tools. Your main
-
(minimum CEFR B22, also checked at interview). v) A draft Individual Career Development Plan (ICDP). vi) Two reference letters. vii) Any additional documents to support the application. viii) Ethical
-
Description of the workplace The Department of Immunotechnology conducts research ranging from advanced technology development to biomedical studies. The main research areas include immuno-oncology